摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5R,6S)-4-methoxy-5-(4-methoxybenzyloxy)-6-(1-phenylethyl)-5,6-dihydro-2H-pyran-2-one | 259142-63-7

中文名称
——
中文别名
——
英文名称
(5R,6S)-4-methoxy-5-(4-methoxybenzyloxy)-6-(1-phenylethyl)-5,6-dihydro-2H-pyran-2-one
英文别名
(5R,6S)-4-methoxy-5-(4-methoxybenzyloxy)-6-phenethyl-5,6-dihydro-2H-pyran-2-one;(2S,3R)-4-methoxy-3-[(4-methoxyphenyl)methoxy]-2-(2-phenylethyl)-2,3-dihydropyran-6-one
(5R,6S)-4-methoxy-5-(4-methoxybenzyloxy)-6-(1-phenylethyl)-5,6-dihydro-2H-pyran-2-one化学式
CAS
259142-63-7
化学式
C22H24O5
mdl
——
分子量
368.43
InChiKey
BPIBTEMXERMGNY-SIKLNZKXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    560.3±50.0 °C(predicted)
  • 密度:
    1.18±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    27
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    54
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (5R,6S)-4-methoxy-5-(4-methoxybenzyloxy)-6-(1-phenylethyl)-5,6-dihydro-2H-pyran-2-one 在 phosphate buffer 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下, 以 二氯甲烷 为溶剂, 以92%的产率得到(+)-dihydrokawain-5-ol
    参考文献:
    名称:
    Facile One-Step Synthesis of β-Alkoxy Lactone via Sequential Lactonization and 1,4-Addition of Alkoxide Group:  Total Synthesis of All Stereoisomers of Dihydrokawain-5-ol
    摘要:
    We describe here a divergent total synthesis of all of the four stereoisomers of dihydrokawain-5-ol starting from alpha-D-glucose. The approach involves the use of Ando's modification of Horner-Wadsworth-Emmons homologation to give a alpha,beta-unsaturated ester. Subsequently, lactonization and 1,4-addition of OMe group in one step provided a delta-lactone, which was converted into the target compounds in two steps.
    DOI:
    10.1021/jo049858n
  • 作为产物:
    参考文献:
    名称:
    Facile One-Step Synthesis of β-Alkoxy Lactone via Sequential Lactonization and 1,4-Addition of Alkoxide Group:  Total Synthesis of All Stereoisomers of Dihydrokawain-5-ol
    摘要:
    We describe here a divergent total synthesis of all of the four stereoisomers of dihydrokawain-5-ol starting from alpha-D-glucose. The approach involves the use of Ando's modification of Horner-Wadsworth-Emmons homologation to give a alpha,beta-unsaturated ester. Subsequently, lactonization and 1,4-addition of OMe group in one step provided a delta-lactone, which was converted into the target compounds in two steps.
    DOI:
    10.1021/jo049858n
点击查看最新优质反应信息

文献信息

  • Asymmetric Synthesis of (+)-Dihydrokawain-5-ol
    作者:Yoshitsugu Arai、Tsutomu Masuda、Shinya Yoneda、Yukio Masaki、Motoo Shiro
    DOI:10.1021/jo991307n
    日期:2000.1.1
  • Facile One-Step Synthesis of β-Alkoxy Lactone via Sequential Lactonization and 1,4-Addition of Alkoxide Group:  Total Synthesis of All Stereoisomers of Dihydrokawain-5-ol
    作者:Ravi P. Singh、Vinod K. Singh
    DOI:10.1021/jo049858n
    日期:2004.5.1
    We describe here a divergent total synthesis of all of the four stereoisomers of dihydrokawain-5-ol starting from alpha-D-glucose. The approach involves the use of Ando's modification of Horner-Wadsworth-Emmons homologation to give a alpha,beta-unsaturated ester. Subsequently, lactonization and 1,4-addition of OMe group in one step provided a delta-lactone, which was converted into the target compounds in two steps.
查看更多

同类化合物

(4-甲氧基-6-[(E)-2-(3-甲氧基苯基)乙烯基]-5,6-二氢-2H-吡 麻醉椒苫素 麻醉椒苦素 醉椒素 甲氧醉椒素 去甲氧基醉椒素 二氢麻醉椒素 二氢醉椒素 二氢醉人素 S(-)-α-甲基苄胺 N-[(1S)-1-(4-甲氧基-6-氧代吡喃-2-基)-2-苯基乙基]乙酰胺 6-[2-(4-羟基苯基)乙烯基]-4-甲氧基吡喃-2-酮 6-[2-(4-羟基苯基)乙烯基]-4-甲氧基吡喃-2-酮 5,6-去氢醉椒素 4-甲氧基-6-[2-(4-甲氧基苯基)乙基]吡喃-2-酮 4-甲氧基-6-(2-苯基乙烯基)-2H-吡喃-2-酮 4-甲氧基-6-(2-苯基乙基)吡喃-2-酮 (5S,6S)-5-乙酰氧基-5,6-二氢-4,6-二甲氧基-6-[(E)-2-苯乙烯基]-2H-吡喃-2-酮 (E)-4-methoxy-6-(2-methoxystyryl)-2H-pyran-2-one 4-methoxy-6-(4-nitrostyryl)-2H-pyran-2-one 6-(4-fluorostyryl)-4-methoxy-2H-pyran-2-one (E)-4-methoxy-6-(4-propylstyryl)-2H-pyran-2-one 6-[(E)-2-(4-chlorophenyl)vinyl]-4-methoxy-2H-pyran-2-one 4-methoxy-6-(p-nitro-trans-styryl)-2H-pyran-2-one (E)-4-methoxy-6-(2-methylstyryl)-2H-pyran-2-one (E)-4-methoxy-6-(3-methylstyryl)-2H-pyran-2-one (E)-6-(4-ethoxystyryl)-4-methoxy-2H-pyran-2-one (S)-4-Ethoxy-6-phenethyl-5,6-dihydro-pyran-2-one 6-[(Z)-2-(3,4-dimethoxyphenyl)ethenyl]-4-methoxy-2H-pyran-2-one 2H-Pyran-2-one, 6-[2-(3,4-dimethoxyphenyl)ethyl]-5,6-dihydro-4-methoxy-, (S)- 2H-Pyran-2-one, 5,6-dihydro-6-[2-(3-hydroxy-4-methoxyphenyl)ethyl]-4-methoxy-, (S)- 4-acetoxy-6-<(E)-2-phenylethenyl>-2H-pyran-2-one Kavain (Z)-6-(4-methoxystyryl)-4-methoxy-5,6-dihydropyran-2-one 7,8-dihydromethysticin aspernigrin B (R)-Methysticin 6,6'-(1E,1'E)-2,2'-(1,4-phenylene)bis(ethene-2,1-diyl)bis(4-methoxy-2H-pyran-2-one) 4-methoxy-6-[2-(1-naphthyl)ethyl]-2H-pyran-2-one 4-methoxy-6-(3',4'-dihydroxystyryl)-2-pyrone 4-methoxy-6-[2-(4-tert-butylphenyl)ethyl]-2H-pyran-2-one 6,6'-(2,2'-(1,4-phenylene)bis(ethane-2,1-diyl))bis(4-methoxy-2H-pyran-2-one) 4-methoxy-6-(3,4,5-trimethoxyphenethyl)-2H-pyran-2-one 6-(3,4-dimethoxyphenethyl)-4-methoxy-2H-pyran-2-one 4-methoxy-6-[2-(2-naphthyl)ethyl]-2H-pyran-2-one (E)-4-methoxy-6-(3,4,5-trimethoxystyryl)-2H-pyran-2-one 4-methoxy-6-[2-(3-(4-tert-butylphenoxy)phenyl)ethyl]-2H-pyran-2-one O-Methyl-hispidin 4-methoxy-6-(3-nitrostyryl)-2H-pyran-2-one (E)-6-(4-(dimethylamino)styryl)-4-methoxy-2H-pyran-2-one